FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 341:1639-1644 November 25, 1999 Number 22 Next

	Full Text PDF Editorial by Eskenazi, B. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Whether the consumption of caffeine during pregnancy increases the risk of spontaneous abortion is controversial. Prior studies have determined caffeine consumption by questionnaire. We used a biologic marker, serum paraxanthine, a metabolite of caffeine, to measure the dose of caffeine.

Methods In a nested case–control study, we measured serum paraxanthine in 591 women who had spontaneous abortions at less than 140 days' gestation and in 2558 matched women from the same clinic who gave birth to live infants at 28 weeks' gestation or later and who had serum drawn on the same day of gestation as the women who had abortions. The women were enrolled in the Collaborative Perinatal Project during the period from 1959 to 1966, and serum paraxanthine was measured over 30 years later.

Results A total of 487 women who had spontaneous abortions (82 percent) and 2087 controls (82 percent) had quantifiable serum paraxanthine concentrations. However, the mean serum paraxanthine concentration was higher in the women who had spontaneous abortions than in the controls (752 vs. 583 ng per milliliter, P<0.001). The odds ratio for spontaneous abortion was not significantly elevated in the women who had serum paraxanthine concentrations of 1845 ng per milliliter or lower, corresponding to the 95th percentile of the matched women. However, the adjusted odds ratio for spontaneous abortion among women with serum paraxanthine concentrations higher than 1845 ng per milliliter, as compared with women who had concentrations below 50 ng per milliliter, was 1.9 (95 percent confidence interval, 1.2 to 2.8).

Conclusions Only extremely high serum paraxanthine concentrations are associated with spontaneous abortion. This suggests that moderate consumption of caffeine is unlikely to increase the risk of spontaneous abortion.

Source Information

From the Division of Epidemiology, Statistics, and Prevention Research, National Institute of Child Health and Human Development, Bethesda, Md. (M.A.K., R.J.L., R.D., J.D.C.); and the Center for Human Toxicology, University of Utah, Salt Lake City (D.G.W.).

Address reprint requests to Dr. Klebanoff at the Division of Epidemiology, Statistics, and Prevention Research, National Institute of Child Health and Human Development, National Institutes of Health, 6100 Bldg., Rm. 7B03, MSC 7510, Bethesda, MD 20892-7510, or at mk90h{at}nih.gov.

Full Text of this Article

This article has been cited by other articles:

• CARE Study Group, (2008). Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study. BMJ 337: a2332-a2332 [Abstract] [Full Text]  
• Mongraw-Chaffin, M. L., Cohn, B. A., Cohen, R. D., Christianson, R. E. (2008). Maternal Smoking, Alcohol Consumption, and Caffeine Consumption during Pregnancy in Relation to a Son's Risk of Persistent Cryptorchidism: A Prospective Study in the Child Health and Development Studies Cohort, 1959-1967. Am J Epidemiol 167: 257-261 [Abstract] [Full Text]  
• Whitcomb, B. W., Schisterman, E. F., Klebanoff, M. A., Baumgarten, M., Rhoton-Vlasak, A., Luo, X., Chegini, N. (2007). Circulating Chemokine Levels and Miscarriage. Am J Epidemiol 166: 323-331 [Abstract] [Full Text]  
• Pepper, G. V, Craig Roberts, S (2006). Rates of nausea and vomiting in pregnancy and dietary characteristics across populations. Proc R Soc B 273: 2675-2679 [Abstract] [Full Text]  
• Grosso, L. M., Triche, E. W., Belanger, K., Benowitz, N. L., Holford, T. R., Bracken, M. B. (2006). Caffeine Metabolites in Umbilical Cord Blood, Cytochrome P-450 1A2 Activity, and Intrauterine Growth Restriction. Am J Epidemiol 163: 1035-1041 [Abstract] [Full Text]  
• Bech, B. H., Nohr, E. A., Vaeth, M., Henriksen, T. B., Olsen, J. (2005). Coffee and Fetal Death: A Cohort Study with Prospective Data. Am J Epidemiol 162: 983-990 [Abstract] [Full Text]  
• Sata, F., Yamada, H., Suzuki, K., Saijo, Y., Kato, E. H, Morikawa, M., Minakami, H., Kishi, R. (2005). Caffeine intake, CYP1A2 polymorphism and the risk of recurrent pregnancy loss. Mol Hum Reprod 11: 357-360 [Abstract] [Full Text]  
• Saijo, Y., Sata, F., Yamada, H., Suzuki, K., Sasaki, S., Kondo, T., Gong, Y.Y., Kato, E.H., Shimada, S., Morikawa, M., Minakami, H., Kishi, R. (2004). Ah receptor, CYP1A1, CYP1A2 and CYP1B1 gene polymorphisms are not involved in the risk of recurrent pregnancy loss. Mol Hum Reprod 10: 729-733 [Abstract] [Full Text]  
• Tolstrup, J.S., Kjaer, S.K., Munk, C., Madsen, L.B., Ottesen, B., Bergholt, T., Gronbaek, M. (2003). Does caffeine and alcohol intake before pregnancy predict the occurrence of spontaneous abortion?. Hum Reprod 18: 2704-2710 [Abstract] [Full Text]  
• Bracken, M. B., Triche, E. W., Belanger, K., Hellenbrand, K., Leaderer, B. P. (2003). Association of Maternal Caffeine Consumption with Decrements in Fetal Growth. Am J Epidemiol 157: 456-466 [Abstract] [Full Text]  
• Albina, M. L., Colomina, M. T., Sanchez, D. J., Torrente, M., Domingo, J. L. (2002). Interactions of Caffeine and Restraint Stress During Pregnancy in Mice. Exp. Biol. Med. 227: 779-785 [Abstract] [Full Text]  
• Lawson, C. C., LeMasters, G. K., Levin, L. S., Liu, J. H. (2002). Pregnancy Hormone Metabolite Patterns, Pregnancy Symptoms, and Coffee Consumption. Am J Epidemiol 156: 428-437 [Abstract] [Full Text]  
• Biaggioni, I., Davis, S. N. (2002). Caffeine: A Cause of Insulin Resistance?. Diabetes Care 25: 399-400 [Full Text]  
• Klebanoff, M. A., Levine, R. J., Clemens, J. D., Wilkins, D. G. (2002). Maternal Serum Caffeine Metabolites and Small-for-Gestational Age Birth. Am J Epidemiol 155: 32-37 [Abstract] [Full Text]  
• Johansson, B., Halldner, L., Dunwiddie, T. V., Masino, S. A., Poelchen, W., Gimenez-Llort, L., Escorihuela, R. M., Fernandez-Teruel, A., Wiesenfeld-Hallin, Z., Xu, X.-J., Hardemark, A., Betsholtz, C., Herlenius, E., Fredholm, B. B. (2001). Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. USA 10.1073/pnas.161292398v1 [Abstract] [Full Text]  
• Cnattingius, S., Signorello, L. B., Anneren, G., Clausson, B., Ekbom, A., Ljunger, E., Blot, W. J., McLaughlin, J. K., Petersson, G., Rane, A., Granath, F. (2000). Caffeine Intake and the Risk of First-Trimester Spontaneous Abortion. NEJM 343: 1839-1845 [Abstract] [Full Text]  
• Torfs, C. P., Christianson, R. E. (2000). Effect of Maternal Smoking and Coffee Consumption on the Risk of Having a Recognized Down Syndrome Pregnancy. Am J Epidemiol 152: 1185-1191 [Abstract] [Full Text]  
• (2000). Coffee Drinking and the Risk for Miscarriage. Journal Watch Dermatology 2000: 20-20 [Full Text]  
• (2000). Caffeine Does Not Increase Risk for Spontaneous Abortion. JWatch Women's Health 2000: 16-16 [Full Text]  
• (1999). Coffee Drinking and the Risk for Miscarriage. JWatch General 1999: 5-5 [Full Text]  
• Eskenazi, B. (1999). Caffeine -- Filtering the Facts. NEJM 341: 1688-1689 [Full Text]  
• Johansson, B., Halldner, L., Dunwiddie, T. V., Masino, S. A., Poelchen, W., Gimenez-Llort, L., Escorihuela, R. M., Fernandez-Teruel, A., Wiesenfeld-Hallin, Z., Xu, X.-J., Hardemark, A., Betsholtz, C., Herlenius, E., Fredholm, B. B. (2001). Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. USA 98: 9407-9412 [Abstract] [Full Text]